Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 12 of about 12 for Merck & Co, Inc.�
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 53.05 -0.46 (-0.86%) 1.06B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 59.66 +0.28 (0.47%) 170.08B
Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 1.06 +0.01 (0.95%) 46.79M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Alkermes Plc NASDAQ ALKS 56.40 +1.15 (2.09%) 8.25B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Xenon Pharmaceuticals Inc NASDAQ XENE 12.65 -0.52 (-3.95%) 179.37M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Nektar Therapeutics NASDAQ NKTR 14.67 +0.35 (2.44%) 1.88B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 47.87 +0.64 (1.36%)
Amphastar Pharmaceuticals Inc NASDAQ AMPH 10.56 +0.08 (0.76%) 471.49M
Amphastar Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and ...
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.822 -0.006 (-0.72%)
ALKERMES PLC DL-,01 FRA 8AK 44.12 +0.96 (2.23%)
NEKTAR THERAPEUTICS FRA ITH 11.76 +0.95 (8.81%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.000